Nine researchers receive the 2017 NIH Director’s New Innovator Award for cancer-related discoveries October 13, 2017Vol.43 No.38
Conversation with The Cancer Letter Rubin: FDA helped Merck figure out how to channel science into regulatory approval October 13, 2017Vol.43 No.38By Paul Goldberg
Conversation with The Cancer Letter Lemery: “We saw consistent evidence of the drug’s response in multiple tumor types” October 13, 2017Vol.43 No.38By Paul Goldberg
NIH announces immunotherapy consortium with 11 companies to support Cancer Moonshot goals October 13, 2017Vol.43 No.38By Matthew Bin Han Ong
FDA: the development of site-agnostic indications calls for development of sponsor-agnostic diagnostics October 13, 2017Vol.43 No.38By Paul Goldberg
